gt005
Gene therapyexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Dec 17, 2018 (NCT03846193)
Timeline
Indications
Mechanism of action
- Complement C1sACTIVATOR
C1S activator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05481827 | Phase 2 | Jul 12, 2022 | Gyroscope Therapeutics, Novartis |
| NCT04566445 | Phase 2 | Nov 11, 2020 | Gyroscope Therapeutics |
| NCT04437368 | Phase 2 | Jul 15, 2020 | Gyroscope Therapeutics |
| NCT03846193 | Phase 1/Phase 2 (Phase 2) | Dec 17, 2018 | Gyroscope Therapeutics |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Gyroscope Therapeutics | For profit | 4 | 4 | 1 | 2018 |
| Novartis | For profit | 1 | 0 | 1 | 2022 |
2 organizations
Page 1 / 1